Copyright
©The Author(s) 2020.
World J Clin Cases. Dec 6, 2020; 8(23): 5999-6008
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.5999
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.5999
Table 1 Baseline characteristics of the patients included in each group
| Group | Modified VM | Standard VM | χ2/t | P value |
| Patients (n) | 180 | 181 | ||
| Men [n (%)] | 84 (46.7) | 74 (40.88) | 1.226 | 0.290 |
| Age (yr) | 51.76 ± 12.02 | 49.29 ± 13.59 | 1.823 | 0.069 |
| Weight (kg) | 64.89 ± 20.82 | 68.22 ± 13.27 | -1.815 | 0.070 |
| Duration of PSVT (yr) | 7.27 ± 7.38 | 8.60 ± 8.10 | -1.630 | 0.104 |
| Systolic BP (mmHg) | 127.42 ± 28.67 | 132.35 ± 19.46 | -1.913 | 0.057 |
| Diastolic BP (mmHg) | 79.61 ± 18.17 | 82.77 ± 12.81 | -1.912 | 0.057 |
| Pulse (bpm) | 75.71 ± 18.26 | 79.18 ± 15.22 | -1.962 | 0.051 |
| Serum potassium (mmol/L) | 3.94 ± 0.89 | 4.08 ± 0.51 | -1.826 | 0.069 |
| Coronary heart disease [n (%)] | 2 (1.11) | 8 (4.42) | 3.668 | 0.105 |
| Hypertension [n (%)] | 36 (2.00) | 44 (24.31) | 0.972 | 0.375 |
| Diabetes [n (%)] | 10 (5.56) | 10 (5.52) | 0.000 | 1.000 |
| Pneumonia [n (%)] | 2 (1.11) | 0 (0.00) | 2.022 | 0.155 |
- Citation: Wang W, Jiang TF, Han WZ, Jin L, Zhao XJ, Guo Y. Efficacy and economic benefits of a modified Valsalva maneuver in patients with paroxysmal supraventricular tachycardia. World J Clin Cases 2020; 8(23): 5999-6008
- URL: https://www.wjgnet.com/2307-8960/full/v8/i23/5999.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i23.5999